Search Results - "Schädlich, Lysann"

A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody Response by Thönes, Nadja, Herreiner, Anna, Schädlich, Lysann, Piuko, Konrad, Müller, Martin

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Analysis of Modified Human Papillomavirus Type 16 L1 Capsomeres: the Ability To Assemble into Larger Particles Correlates with Higher Immunogenicity by Schädlich, Lysann, Senger, Tilo, Gerlach, Britta, Mücke, Norbert, Klein, Corinna, Bravo, Ignacio G, Müller, Martin, Gissmann, Lutz

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Identification of B-Cell Epitopes on Virus-Like Particles of Cutaneous Alpha-Human Papillomaviruses by SENGER, Tilo, BECKER, Maria R, SCHÄDLICH, Lysann, WATERBOER, Tim, GISSMANN, Lutz

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Refining HPV 16 L1 purification from E. coli : Reducing endotoxin contaminations and their impact on immunogenicity by Schädlich, Lysann, Senger, Tilo, Kirschning, Carsten J, Müller, Martin, Gissmann, Lutz

“…Abstract HPV 16 L1 capsomeres purified from Escherichia coli represent a promising and potentially cost-effective alternative to the recently licensed…”
Get full text

Enhanced papillomavirus-like particle production in insect cells by Senger, Tilo, Schädlich, Lysann, Gissmann, Lutz, Müller, Martin

“…Abstract Human papillomavirus (HPV) L1 self-assembles into virus-like particles (VLPs), which are the basis for the two commercially available prophylactic…”
Get full text

Tumor prevention in HPV8 transgenic mice by HPV8-E6 DNA vaccination by Marcuzzi, Gian Paolo, Awerkiew, Sabine, Hufbauer, Martin, Schädlich, Lysann, Gissmann, Lutz, Eming, Sabine, Pfister, Herbert

“…The genus beta human papillomavirus 8 (HPV8) is involved in the development of cutaneous squamous cell carcinomas (SCCs) in individuals with epidermodysplasia…”
Get full text

Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs by Senger, Tilo, Schädlich, Lysann, Textor, Sonja, Klein, Corinna, Michael, Kristina M, Buck, Christopher B, Gissmann, Lutz

“…Abstract The potential as prophylactic vaccines of L1-based particles from cutaneous genus alpha human papillomavirus (HPV) types has not been assessed so far…”
Get full text

Human papillomavirus-specific immune therapy: failure and hope by Nieto, Karen, Gissmann, Lutz, Schädlich, Lysann

“…Recently, two prophylactic vaccines against the most significant oncogenic human papillomaviruses (HPV; 16 and 18) became available that efficiently protect…”
Get more information

Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model by López-Toledo, Gabriela, Schädlich, Lysann, Alonso-Castro, Ángel Josabad, Monroy-García, Alberto, García-Rocha, Rosario, Guido, Miriam C, Gissmann, Lutz, García-Carrancá, Alejandro

“…Development of cervical cancer is associated with persistent infections by high-risk human papillomavirus (HPV). Although current HPV L1-based prophylactic…”
Get more information

Evaluation of specific humoral and cellular immune responses against the major capsid L1 protein of cutaneous wart-associated alpha-Papillomaviruses in solid organ transplant recipients by Gaiser, Maria R, Textor, Sonja, Senger, Tilo, Schädlich, Lysann, Waterboer, Tim, Kaufmann, Andreas M, Süsal, Caner, Pawlita, Michael, Enk, Alexander H, Gissmann, Lutz, Lonsdorf, Anke S

“…Highlights • We analyzed HPV-specific immune responses in organ transplant recipients. • Main cellular immune response against any HPV type was of TH1 type. •…”
Get full text

Refining HPV 16 L1 purification fromE. coli: Reducing endotoxin contaminations and their impact on immunogenicity by Schädlich, Lysann, Senger, Tilo, Kirschning, Carsten J, Müller, Martin, Gissmann, Lutz

“…HPV 16 L1 capsomeres purified fromEscherichia colirepresent a promising and potentially cost-effective alternative to the recently licensed VLP-based vaccines…”
Get full text

Development of a novel recombinant encapsidated RNA particle: Evaluation as an internal control for diagnostic RT-PCR by King, Donald P., Montague, Nick, Ebert, Katja, Reid, Scott M., Dukes, Juliet P., Schädlich, Lysann, Belsham, Graham J., Lomonossoff, George P.

“…This report describes the generation of novel encapsidated RNA particles and their evaluation as in-tube internal controls in diagnostic real-time…”
Get full text